Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Clarke

Showing results (381-390 of 441) with videos related to

Pageof 45
Sort By:
Molecular Therapy Oncolytics|July 13, 2018
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV<sup>POS</sup> CancersLukkana Suksanpaisan, Rong Xu, Mulu Z Tesfay, et al.
Translational Psychiatry|October 8, 2014
αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humansA C Easton, A Lourdusamy, M Havranek, et al.
Translational Psychiatry|November 2, 2016
Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohortsH C Whalley, M J Adams, L S Hall, et al.
Translational Psychiatry|April 19, 2017
Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association dataJ Gibson, T C Russ, M J Adams, et al.
Journal of Virology|April 14, 2006
Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challengeRobert J Natuk, David Cooper, Min Guo, et al.
The Lancet. Infectious Diseases|January 19, 2020
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trialDavid K Clarke, Rong Xu, Demetrius Matassov, et al.
Journal of Virology|November 17, 2017
Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus ChallengeDemetrius Matassov, Chad E Mire, Theresa Latham, et al.
Drug and Alcohol Dependence|July 17, 2012
Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populationsR C Crist, L M Ambrose-Lanci, M Vaswani, et al.
Environmental Monitoring and Assessment|September 19, 2022
A novel method for identifying coded tags recorded on aquatic acoustic monitoring systemsChristopher D Lowe, Nicolas J C Tregenza, Claudia J Allen, et al.
Translational Psychiatry|August 16, 2017
Do regional brain volumes and major depressive disorder share genetic architecture? A study of Generation Scotland (n=19 762), UK Biobank (n=24 048) and the English Longitudinal Study of Ageing (n=5766)E M Wigmore, T-K Clarke, D M Howard, et al.
Pageof 45

Showing results (381-390 of 441) with videos related to

Sort By:
Pageof 45
Molecular Therapy Oncolytics|July 13, 2018
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV<sup>POS</sup> CancersLukkana Suksanpaisan, Rong Xu, Mulu Z Tesfay, et al.
Translational Psychiatry|October 8, 2014
αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humansA C Easton, A Lourdusamy, M Havranek, et al.
Translational Psychiatry|November 2, 2016
Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohortsH C Whalley, M J Adams, L S Hall, et al.
Translational Psychiatry|April 19, 2017
Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association dataJ Gibson, T C Russ, M J Adams, et al.
Journal of Virology|April 14, 2006
Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challengeRobert J Natuk, David Cooper, Min Guo, et al.
The Lancet. Infectious Diseases|January 19, 2020
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trialDavid K Clarke, Rong Xu, Demetrius Matassov, et al.
Journal of Virology|November 17, 2017
Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus ChallengeDemetrius Matassov, Chad E Mire, Theresa Latham, et al.
Drug and Alcohol Dependence|July 17, 2012
Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populationsR C Crist, L M Ambrose-Lanci, M Vaswani, et al.
Environmental Monitoring and Assessment|September 19, 2022
A novel method for identifying coded tags recorded on aquatic acoustic monitoring systemsChristopher D Lowe, Nicolas J C Tregenza, Claudia J Allen, et al.
Translational Psychiatry|August 16, 2017
Do regional brain volumes and major depressive disorder share genetic architecture? A study of Generation Scotland (n=19 762), UK Biobank (n=24 048) and the English Longitudinal Study of Ageing (n=5766)E M Wigmore, T-K Clarke, D M Howard, et al.
Pageof 45